Independent guidance
Practical information services for service members, veterans, families, and supporters trying to understand ibogaine’s evidence, safety concerns, legal status, and possible military consequences.
Information first: evidence, uncertainty, risk, and military context in one place.
What this page offers
Wide Anchor 68 is an independent resource, not a provider of ibogaine treatment. Our services are informational: guides, comparisons, research summaries, decision frameworks, glossary explanations, and frequently asked questions for people navigating a complex subject.
The broader ibogaine information for service members begins with a simple premise: serious risks and uncertainty deserve plain language. For the purpose, independence, and limits of this resource, see how Wide Anchor 68 approaches the subject.
“Good information does not make the decision for someone. It makes the decision’s stakes easier to see.”
Information services
Each offering is designed to help readers distinguish what is known, what is uncertain, and what needs qualified medical or legal advice beyond this site.
Topic guides put ibogaine’s reported uses, legal position, safety concerns, and military context into an orderly starting point. They are intended for careful reading, not for self-treatment or a substitute for clinical assessment.
Plain-language prompts help readers consider medical history, medication interactions, screening claims, travel questions, command implications, and the difference between personal accounts and reliable evidence.
Comparisons outline practical distinctions people may encounter while researching options, including travel and cost claims. For example, this independent overview of ibogaine treatment costs in Mexico can help readers identify the questions a price discussion alone cannot answer.
Research summaries separate early findings and anecdotal reports from established care. Ibogaine is listed as a Schedule I controlled substance by the DEA in the United States, a legal fact that is central to any responsible discussion for service members.
Research should be read alongside safety, law, and individual circumstances.
Why context matters
Ibogaine has been discussed in relation to substance use and other concerns, but its risks can be serious. The U.S. Food and Drug Administration notes that unapproved drugs have not been reviewed for safety and effectiveness; its overview of unapproved drugs is relevant context when evaluating treatment claims.
Our summaries also point readers toward terms they may see in studies, clinic marketing, or community discussion. A basic account of ibogaine’s pharmacology and history can be useful background, but it does not settle questions about individual suitability, medication safety, or military consequences.
Common questions
No. Wide Anchor 68 provides information, not diagnoses, treatment plans, or medical clearance. Individual risk questions require qualified medical attention, especially where heart health, psychiatric history, or medication interactions may be involved.
Military status can add practical considerations to an already complex subject, including fitness, duty, records, reporting obligations, travel, and legal exposure. The veterans frequently asked questions organize several of those concerns in plain language.
Use them to identify questions, not as endorsements. A comparison can clarify what is being promised, what evidence is cited, what screening is described, and what remains unknown. For focused risk context, review the site’s safety considerations for ibogaine.
Start with context
Use the guides to build a clearer understanding of ibogaine before relying on marketing, anecdotes, or a single source of information.